Cargando...

Tocilizumab: The evidence for its place in the treatment of juvenile idiopathic arthritis

INTRODUCTION: Juvenile idiopathic arthritis (JIA) is one of the most common chronic diseases with childhood onset. It comprises different subtypes of which the systemic onset subtype is often resistant to treatment. With the advent of biological treatment with tumor necrosis factor-α (TNFα)-inhibito...

Descrición completa

Gardado en:
Detalles Bibliográficos
Autor Principal: Herlin, Troels
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2010
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2899792/
https://ncbi.nlm.nih.gov/pubmed/20694074
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!